We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+3.15%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.85B
AUM Growth
-$153M
Cap. Flow
-$306M
Cap. Flow %
-7.96%
Top 10 Hldgs %
17.74%
Holding
705
New
68
Increased
289
Reduced
229
Closed
52

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$22.5M
2
AET
Aetna Inc
AET
+$21.5M
3
JNJ icon
Johnson & Johnson
JNJ
+$20.4M
4
ADI icon
Analog Devices
ADI
+$19.4M
5
CMI icon
Cummins
CMI
+$17.3M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$43.9M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$40.1M
3
ABBV icon
AbbVie
ABBV
+$37.1M
4
GILD icon
Gilead Sciences
GILD
+$24.2M
5
PH icon
Parker-Hannifin
PH
+$22.4M

Sector Composition

Rank Sector Weight
1 Healthcare 24.55%
2 Financials 13.06%
3 Technology 10.24%
4 Consumer Staples 10.19%
5 Communication Services 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
O icon
426
Realty Income
O
$61.2B
$982K 0.03%
+14,605
New +$886K
SCHW
427
Charles Schwab
SCHW
$177B
$979K 0.03%
38,665
+9,965
+35% +$283K
ENB icon
428
Enbridge
ENB
$124B
$975K 0.03%
23,129
-564
-2% -$23K
XEL icon
429
Xcel Energy
XEL
$51B
$973K 0.03%
21,717
+4,076
+23% +$169K
HPQ icon
430
HP
HPQ
$23.5B
$969K 0.03%
77,233
+4,835
+7% +$60.2K
TRIL
431
DELISTED
Trillium Therapeutics Inc.
TRIL
$969K 0.03%
110,000
DINO icon
432
HF Sinclair
DINO
$15.9B
$965K 0.03%
40,583
+13,031
+47% +$388K
AKAM icon
433
Akamai
AKAM
$16.8B
$963K 0.03%
17,225
+2,627
+18% +$138K
TDG icon
434
TransDigm Group
TDG
$69.2B
$949K 0.02%
3,599
+1,266
+54% +$309K
CTAS icon
435
Cintas
CTAS
$82.4B
$943K 0.02%
38,420
+18,508
+93% +$426K
DG icon
436
Dollar General
DG
$25.9B
$943K 0.02%
10,034
-3,050
-23% -$263K
ADM icon
437
Archer Daniels Midland
ADM
$41.4B
$937K 0.02%
21,850
+1,982
+10% +$79K
HUM icon
438
Humana
HUM
$46.7B
$934K 0.02%
5,190
-13,518
-72% -$2.4M
PPL
439
PPL Corp
PPL
$27.3B
$927K 0.02%
24,554
-126,246
-84% -$4.81M
WU icon
440
Western Union
WU
$2.57B
$926K 0.02%
48,295
+192
+0.4% +$3.73K
AZO icon
441
AutoZone
AZO
$48.3B
$914K 0.02%
1,151
-4,474
-80% -$3.45M
STT icon
442
State Street
STT
$50.9B
$910K 0.02%
16,882
+4,153
+33% +$248K
CHL
443
DELISTED
China Mobile Limited
CHL
$909K 0.02%
15,705
TCOM icon
444
Trip.com Group
TCOM
$27.5B
$906K 0.02%
22,000
+14,000
+175% +$611K
WELL icon
445
Welltower
WELL
$178B
$897K 0.02%
11,782
+1,378
+13% +$97.9K
L icon
446
Loews
L
$24.3B
$894K 0.02%
21,750
+4,459
+26% +$177K
TPR icon
447
Tapestry
TPR
$28.8B
$892K 0.02%
21,902
-1,939
-8% -$76.4K
DOC icon
448
Healthpeak Properties
DOC
$15.4B
$885K 0.02%
27,458
+758
+3% +$23.5K
ORLY icon
449
O'Reilly Automotive
ORLY
$72.4B
$884K 0.02%
48,930
+9,495
+24% +$168K
ZAYO
450
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$880K 0.02%
31,500

Similar funds

Candriam SCA's Q2 2016 Portfolio in Review

As of Q2 2016, Candriam SCA held 705 positions worth $3.85B, down 3.8% from $4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA withdrew a net $306M in Q2 2016, closing 52 positions and reducing 229 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $9.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in NiSource worth $14.5M.

  • Candriam SCA's largest Q2 2016 buy was NiSource: 547,430 shares worth $14.5M.
  • Candriam SCA added most to Abbott in Q2 2016, an estimated $22.5M increase.
  • Candriam SCA's biggest Q2 2016 reduction was Intel, cutting an estimated $43.9M.
  • Candriam SCA fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $9.2M.
  • Candriam SCA's ten largest holdings make up 18% of its $3.85B portfolio in Q2 2016.
  • Candriam SCA opened 68 new positions and closed 52 in Q2 2016.
  • Candriam SCA's portfolio value fell 3.8% quarter-over-quarter to $3.85B.

Based on Candriam SCA's 13F filing for Q2 2016, filed 26 Jul 2016.